| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Insight Molecular Diagnostics Inc.
13D/A
Amendment 14
IMDX · 68235C206
|
39.7% |
4/27/2026
Event 4/23/2026
|
|||
| Broadwood Partners, L.P. | 39.7% | ||||
| Broadwood Capital, Inc. | 39.7% | ||||
| Neal C. Bradsher | 39.7% | ||||
|
STAAR Surgical Company
13D/A
Amendment 44
STAA · 852312305
|
32.6% |
3/13/2026
Event 3/13/2026
|
|||
| Broadwood Partners, L.P. | 32.6% | ||||
| Broadwood Capital, Inc. | 32.6% | ||||
| Neal C. Bradsher | 32.6% | ||||
| Richard T. LeBuhn | 0% | ||||
|
Insight Molecular Diagnostics Inc.
13D/A
Amendment 13
IMDX · 68235C206
|
37.4% |
2/12/2026
Event 2/10/2026
|
|||
| Broadwood Partners, L.P. | 37.4% | ||||
| Broadwood Capital, Inc. | 37.4% | ||||
| Neal C. Bradsher | 37.4% | ||||
|
Staar Surgical Co
13D/A
Amendment 43
STAA · 852312305
|
31.1% |
1/16/2026
Event 1/14/2026
|
|||
| Broadwood Partners, L.P. | 31.1% | ||||
| Broadwood Capital, Inc. | 31.1% | ||||
| Neal C. Bradsher | 31.1% | ||||
| Richard T. LeBuhn | 0% | ||||
| Natalie R. Capasso | 0% | ||||
| Raymond A. Myers | 0% | ||||
| Jason J. Martin | 0% | ||||
|
Staar Surgical Co
13D/A
Amendment 42
STAA · 852312305
|
30.2% |
12/17/2025
Event 12/15/2025
|
|||
| Broadwood Partners, L.P. | 30.2% | ||||
| Broadwood Capital, Inc. | 30.2% | ||||
| Neal C. Bradsher | 30.2% | ||||
| Richard T. LeBuhn | 0% | ||||
| Natalie R. Capasso | 0% | ||||
| Raymond A. Myers | 0% | ||||
| Jason J. Martin | 0% | ||||
|
Staar Surgical Co
13D/A
Amendment 41
STAA · 852312305
|
30.2% |
11/21/2025
Event 11/20/2025
|
|||
| Broadwood Partners, L.P. | 30.2% | ||||
| Broadwood Capital, Inc. | 30.2% | ||||
| Neal C. Bradsher | 30.2% | ||||
| Richard T. LeBuhn | 0% | ||||
| Natalie R. Capasso | 0% | ||||
| Raymond A. Myers | 0% | ||||
| Jason J. Martin | 0% | ||||
|
Lineage Cell Therapeutics, Inc.
13D/A
Amendment 29
LCTX · 53566P109
|
23.1% |
11/14/2025
Event 11/12/2025
|
|||
| Broadwood Partners, L.P. | 23.0% | ||||
| Broadwood Capital, Inc. | 23.0% | ||||
| Neal C. Bradsher | 23.1% | ||||
|
Staar Surgical Co
13D/A
Amendment 40
STAA · 852312305
|
27.4% |
10/24/2025
Event 10/22/2025
|
|||
| Broadwood Partners, L.P. | 27.4% | ||||
| Broadwood Capital, Inc. | 27.4% | ||||
| Neal C. Bradsher | 27.4% | ||||
| Richard T. LeBuhn | 0% | ||||
| Natalie R. Capasso | 0% | ||||
| Raymond A. Myers | 0% | ||||
| Jason J. Martin | 0% | ||||
|
Staar Surgical Co
13D/A
Amendment 39
STAA · 852312305
|
27.4% |
10/22/2025
Event 10/21/2025
|
|||
| Broadwood Partners, L.P. | 27.4% | ||||
| Broadwood Capital, Inc. | 27.4% | ||||
| Neal C. Bradsher | 27.4% | ||||
| Richard T. LeBuhn | 0% | ||||
| Natalie R. Capasso | 0% | ||||
| Raymond A. Myers | 0% | ||||
| Jason J. Martin | 0% | ||||
|
Staar Surgical Co
13D/A
Amendment 38
STAA · 852312305
|
27.4% |
9/26/2025
Event 9/24/2025
|
|||
| Broadwood Partners, L.P. | 27.4% | ||||
| Broadwood Capital, Inc. | 27.4% | ||||
| Neal C. Bradsher | 27.4% | ||||
| Richard T. LeBuhn | 0% | ||||
| Natalie R. Capasso | 0% | ||||
| Raymond A. Myers | 0% | ||||
| Jason J. Martin | 0% | ||||
|
Staar Surgical Co
13D/A
Amendment 37
STAA · 852312305
|
27.4% |
9/17/2025
Event 9/15/2025
|
|||
| Broadwood Partners, L.P. | 27.4% | ||||
| Broadwood Capital, Inc. | 27.4% | ||||
| Neal C. Bradsher | 27.4% | ||||
| Richard T. LeBuhn | 0% | ||||
| Natalie R. Capasso | 0% | ||||
| Raymond A. Myers | 0% | ||||
| Jason J. Martin | 0% | ||||
|
Staar Surgical Co
13D/A
Amendment 36
STAA · 852312305
|
27.3% |
9/2/2025
Event 9/2/2025
|
|||
| Broadwood Partners, L.P. | 27.3% | ||||
| Broadwood Capital, Inc. | 27.3% | ||||
| Neal C. Bradsher | 27.3% | ||||
|
STAAR Surgical Company
13D/A
Amendment 35
STAA · 852312305
|
27.3% |
8/8/2025
Event 8/7/2025
|
|||
| Broadwood Partners, L.P. | 27.3% | ||||
| Broadwood Capital, Inc. | 27.3% | ||||
| Neal C. Bradsher | 27.3% | ||||
|
Staar Surgical Co
13D/A
Amendment 34
STAA · 852312305
|
27.1% |
4/7/2025
Event 4/4/2025
|
|||
| Broadwood Partners, L.P. | 27.0% | ||||
| Broadwood Capital Inc. | 27.0% | ||||
| Bradsher, Neal C. | 27.1% | ||||
|
Staar Surgical Co
13D/A
Amendment 33
STAA · 852312305
|
25.4% |
4/2/2025
Event 3/31/2025
|
|||
| Broadwood Partners, L.P. | 25.3% | ||||
| Broadwood Capital Inc. | 25.3% | ||||
| Neal C. Bradsher | 25.4% | ||||
|
Staar Surgical Co
13D/A
Amendment 32
STAA · 852312305
|
24.3% |
3/3/2025
Event 2/27/2025
|
|||
| Broadwood Partners, L.P. | 24.2% | ||||
| Broadwood Capital Inc. | 24.2% | ||||
| Bradsher, Neal C. | 24.3% | ||||
|
Oncocyte Corp
13D/A
Amendment 12
IMDX · 68235C206
|
40.2% |
2/10/2025
Event 2/6/2025
|
|||
| Broadwood Partners, L.P. | 40.2% | ||||
| Broadwood Capital Inc. | 40.2% | ||||
| Neal C. Bradsher | 40.2% | ||||
|
Lineage Cell Therapeutics, Inc.
13D/A
Amendment 28
LCTX · 53566P109
|
24.5% |
1/28/2025
Event 1/27/2025
|
|||
| Broadwood Partners, L.P. | 24.3% | ||||
| Broadwood Capital, Inc. | 24.3% | ||||
| Neal C. Bradsher | 24.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.